Jeremy Oryhon, MD
Orthopaedic Surgery · Barrington, ILNPI 1750438560
Payments from drug & device makers
Across 62 payments — averaging $225.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microport Orthopedics Inc$12K
- Smith+Nephew$867
- Zimmer Biomet$731
- Ferring Pharmaceuticals Inc.$148
- Stryker$127
- Pacira Pharmaceuticals Incorporated$53
- plus $93 from 5 others
What the payments were for
- Speaking & faculty fees$7,60454%
- Travel & lodging$4,03729%
- Food & beverage$2,11015%
- Education$2452%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microport Orthopedics Inc | 30 | $11,977 |
| Smith+Nephew | 6 | $867 |
| Zimmer Biomet | 7 | $731 |
| Ferring Pharmaceuticals Inc. | 9 | $148 |
| Stryker | 3 | $127 |
| Pacira Pharmaceuticals Incorporated | 2 | $53 |
| Johnson & Johnson | 1 | $25 |
| Orthofix Medical, Inc. | 1 | $21 |
| KCI USA, Inc. | 1 | $18 |
| Abbott | 1 | $16 |
| Vertex | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MPO Medial Pivot Knee$9,314
- MPO Hip System$2,414
- Oxinium Knees$355
- Journey II BCS$355
- Legion Revision$355
- REDAPT Revision Hip System$355
- Engage Partial Knee System$284
- Oxford-Knees$245
- CORI$149
- Journey II$149
- ROSA$145
- ROSA-Knee$129
How this compares
$13,996 in reported general payments places this provider in the 70th percentile of 844 orthopaedic surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 126 | $3,212 |
| Pregabalin | 57 | $679 |
| Oxycodone Hcl | 172 | $679 |
| Tramadol Hcl | 242 | $567 |
| Methylprednisolone | 81 | $510 |
| Meloxicam | 110 | $417 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 46 | $263 |
| Diclofenac Sodium | 11 | $153 |
| Doxycycline Hyclate | 17 | $131 |
| Tizanidine Hcl | 43 | $94 |
| Amoxicillin | 97 | $67 |
| Ondansetron OdtOndansetron | 11 | $56 |
| Cephalexin | 14 | $48 |
| Clindamycin Hcl | 29 | $14 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Barrington
- Peter BonuttiEffingham$24.3M
- Steven HaddadGlenview$12.6M
- Aaron RosenbergChicago$12.4M
- Treg BrownHerrin$6.6M
- Kamal IbrahimOakbrook Terrace$4.9M
- Wayne GoldsteinMorton Grove$4.9M
- Steven MatherDowners Grove$4.3M
- Steven MardjetkoMorton Grove$4.3M
- Steven ChudikWestmont$4.1M
- Matthew SquireAurora$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.